glp-1 agonist weight loss Rx Trends: Real-World Data on GLP-1s for GLP-1 agonists are part of
Description
Aging Cell
A study by Butler et al
Future research into once-weekly insulins could reduce this number even further
These individual unimolecular multi-agonists activities seemed to harmonize the overall metabolic efficacy, which predominantly results from synergistic glucagon action to increase energy expenditure, GLP-1 action to reduce caloric intake and improve glucose control, and GIP action to potentiate the incretin effect and buffer against the diabetogenic effect of inherent glucagon activity
